Often considered a new gold standard in pharma manufacturing, continuous processing allows drugs to be produced in compact, closed units, with a higher degree of automation and fewer manual interventions. Our coverage of this evolving landscape helps illustrate the issues surrounding the push to condense production steps into a continuous process.
